Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

1.71

Today's Change

+0.06 (3.63%)

Day's Change

1.65 - 1.75

Trading Volume

642,595

Overview

Market Cap

419 Million

Shares Outstanding

246 Million

Avg Volume

4,571,139

Avg Price (50 Days)

2.14

Avg Price (200 Days)

1.68

PE Ratio

-2.13

EPS

-0.80

Earnings Announcement

02-May-2024

Previous Close

1.65

Open

1.73

Day's Range

1.65 - 1.75

Year Range

0.92 - 3.79

Trading Volume

661,719

Price Change Highlight

1 Day Change

3.33%

5 Day Change

10.00%

1 Month Change

-22.85%

3 Month Change

-19.95%

6 Month Change

21.79%

Ytd Change

7.23%

1 Year Change

-28.36%

3 Year Change

-64.77%

5 Year Change

-71.91%

10 Year Change

-84.08%

Max Change

-98.70%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment